7334802970

Nr 1

Interakcje lek-żywność

103 Dzięki dokładnemu poznaniu wzajemnych zależności można uniknąć niebezpiecznych działań niepożądanych leków i poprawić poziom bezpieczeństwa farmakoterapii.

Ł. Sobotta, J. M. Suliburska, J. Mielcarek FOOD - DRUG INTERACTIONS

PIŚMIENNICTWO

I. WHO Medicines: Rational use of medicines. May 2010; http://www.who.int/mediacentre/factsheets/ fs338/en/. - 2. San Miguel M.T., Martinez J.A., Vargas E.: Food-drug interactions in the summary of product characteristics of proprietary medicinal products. Eur. J. Clin. Pharmacol., 2005; 61: 77-83. - 3. Waldman S.A., TerzicA.: Pharmacology and Therapeutics. Saunders, 2009. - 4. HirtzJ.: The gastrointes-tinal absorption of drugs in man: a review of current concepts and methods of investigation. Br. J. Clin. Pharmacol., 1985; 19: 77-83. - 5. McCabe J.B., Frankel E.H., Wolfe J.J.: Food-drug interaction. CRC Press LLC 2003. - 6. Gregg C.R.: Drug interactions and anti-infective therapies. Am. J. Med., 1999; 106: 227-237. - 7. Hay K., Ledikwe J.H., Smiciklas-Wright H., Treu J.\ Nutrition and Aging: Drug-Nutrient Interactions. Nutrition Department, The Pennsylvania State University, 2001: 1-8. - 8. Yen P.K.: Herbal Foods. Geriatrie Nursing, 1999; 20: 111-112. - 9. Leone D., Valenzano A., Grandę G., Santacroce L:. Drug/food interactions: an actual therapeutic outeome. Clin. Ter., 2004; 155(4): 139-47. - 10. Imaura M., Ohno Y., Nakajima K., Suzuki H.\ Clinically significant drug-drug and dmg-food interactions associated with calcium channel blockers. Clin. Calcium., 2005; 15(10): 1709-16.

II. Hacker M, Messer W., Bachmann K.\ Pharmacology. Elsevier Science 2009. - 12. Hallberg L., Brune M., Erlandsson M, SandbergA.S., andRossander-Hulten L.: Calcium: effect of different amounts on nonhemeand heme-iron absorption inhumansl3. Am. J. Clin. Nutr., 1991; 53:112-19. - 13. YetleyE.Y.: Multivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactions. Am. J. Clin. Nutr., 2007; 85: 269-276. - 14. SelhubJ. etal: Association between plasma homocysteine concentrations and extracranialcarotid-artery stenosis. Eng. J. Med., 1995; 332: 286-291.

- 15. Akamine D., Filho M.K., Peres C.M.: Drug-nutrient interactions in elderly people. Curr Opin Clin Nutr Metab Care, 2007; 10(3): 304-310. - 16. Derelanko M.J.: Toxicologist’s pocket handbook. Informa Healthcare 2008. - 17. Huang S.M., Sirong J.M., Zhang L., Reynolds K.S., Nallani S., Tempie R. et al.: New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes Transporters, and the Guidance Process. J. Clin. Pharmacol., 2008; 48(6): 662-670. - 18. Fuhr U., Klitlich K., StaibA.HInhibitory effect of grapefruit juice and its bitter principal, neringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharm., 1993; 35:431-436. - 19. BaileyD.G., Malcolm J, Arnold O., SpenceJ.D.: Grapefruit juice - drug interactions. Br. J. Clin. Pharm., 1998; 46: 101-110. - 20. Shapiro L.E., ShearN.HDrug interactions/P450. Curr Probl Dermatol, 2001: 141-152.

21. Holbrook A.M., Pereira J.A., Labiris R, McDonald H., Douketis J.D., Crowther M, Wells PS.: Systematic overview of warfarin and its drug and food interactions. Arch. Intern. Med., 2005; 165: 1095--1106. - 22. Maintz L., Novak N.: Histaminę and histaminę intolerance. Am. J. Clin. Nutr., 2007; 85: 1185-1196. - 23. Kong L.D., Cheng C.H.K., Tan R.X.: Inhibition of MAO A and MAO B by some plant

- derived alkaloids, phenols and anthraąuinones. J. Ethnopharmacol., 2004; 91: 351-355. - 24. Rapaport M.H.: Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the State of the art. J. Clin. Psychiatry, 2007; 68(8): 42-46. - 25. Bennett W.M.: Drug interactions and conseąuences of sodium restriction. Am. J. Clin. Nutr., 1997; 65: 678-681. - 26. Tanaka E.: Toxicological Interactions Between Alcohol and Benzodiazepines. Clin. Toxicol., 2002; 40(1): 69-75. - 27. Tanaka E., Nakamura T., Terada M., Shinozuka T., Honda K.: A study of the in vitro interaction between ethanol, and triazolam and its two metabolites using human liver microsomes. J. Clin. Foren. Med., 2005; 12, 245-248. - 28. Roine R., Gentry R.T., Hernandez-Munoz R.. Baraona E., et al.: Aspirin inereases blood alcohol concentration in human after ingestion of ethanol. JAMA, 1990; 264: 2406-2408. - 29. Seńczuk W. : Toksykologia. PZWL, Warszawa 2002.

Adres: 60-780 Poznań, ul. Grunwaldzka 6.